Skip to content

Partnering to Enhance Emerging Adults' Response to Programs

Partnering to Enhance Emerging Adults' Response to Programs (PEER)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06115252
Acronym
PEER
Enrollment
248
Registered
2023-11-02
Start date
2025-10-10
Completion date
2028-03-31
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use, Unspecified

Brief summary

The goal of this clinical trial (CT) is to learn more about emerging adults' and their peers. Here, we will see how co-participating with a peer in health program might impact brain and behavior change over time. Eligible youth will be invited to come in for a "Participation Day," during which they and a peer will independently complete questionnaires. With a peer, they will then complete a short health program, and undergo a brain scan (fMRI) while completing activities. Our study team will reach out to each participant individually again 3, 6, and 12 months later to learn about health behaviors over time.

Interventions

BEHAVIORALMotivational Interviewing (MI)

Motivational interviewing with peer dyads starts with an open-ended exploration of the dyad's hazardous drinking behavior via personal stories about alcohol use. It includes a values clarification task and age-matched norms along with personalized feedback regarding the dyad's alcohol use. The goal of the session is to engage the dyad in a thoughtful conversation about drinking and the implications it may have on their lives, with an eye to bolstering and supporting inherent drive for behavior change.

Sponsors

UConn Health
Lead SponsorOTHER
University of Texas
CollaboratorOTHER
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* within the specified age range * agree to be contacted for the 3, 6, and 12 month follow ups * provide fully informed consent

Exclusion criteria

* left-handed * evidence of brain injury/illness and/or neurological, neurodevelopmental disorder including psychosis and related medications (e.g., antipsychotics; neuroleptics) * loss of consciousness ≥ 2 minutes * other fMRI contraindications (e.g., unremovable metal on/in body, pregnant)

Design outcomes

Primary

MeasureTime frameDescription
Blood oxygen level dependent (BOLD) response synchronyBaselineMean BOLD time series will be obtained for each region of interest (ROI) during peer-directed change talk trials and temporally aligned across dyad participants. Inter-brain synchrony will be quantified using z-transformed GLM β-weights within ROIs between the BOLD time series of dyad members.
BOLD response synchrony association with behavior change (past month alcohol use days)12 MonthsPearson correlation coefficients (r) of Primary Outcome #1 (ROI z-scores representing BOLD response synchrony) with individual Timeline Followback (TLFB) past month drinking days at 12 month follow up.

Secondary

MeasureTime frameDescription
BOLD response synchrony association with behavior change (past month alcohol use days)3 MonthsPearson correlation coefficients (r) of Primary Outcome #1 (ROI z-scores representing BOLD response synchrony) with individual Timeline Followback (TLFB) past month drinking days at 3 month follow up.

Countries

United States

Contacts

CONTACTKaren Hudson, MCR
khudson@uchc.edu860-679-1037
PRINCIPAL_INVESTIGATORSarah W. Feldstein Ewing, PhD

UConn Health

PRINCIPAL_INVESTIGATORFrancesca Filbey, PhD

University of Texas

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026